Market, Organizational, and Policy Drivers of Hospital Price Markups for Specialty Drugs

While policymakers are paying attention to drug prices and profits in the retail distribution channel, less is known about the hospital ‘buy and bill’ channel that accounts for one-third of drug expenditures. This research team will quantify trends in price markups and profit margins for hospitals and physician practices from 80 infused drugs, biologics, and biosimilars. This study has implications for policymakers and insurers.